ResearcherUniversity of Maryland, BaltimoreNo recent work listed
Ting Li
Matched on ORCID iD 0000-0002-2027-9462; OpenAlex author ID A5100416865. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper
Papers 5
- The Neutrophil-to-Monocyte Ratio and Platelet-to-White Blood Cell Ratio Represent Novel Prognostic Markers in Patients with Pancreatic Cancer. Co-author DOI 10.1155/2021/6693028↗
- hENT1 reverses chemoresistance by regulating glycolysis in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2020.03.015↗
- LOX and ACSL5 as potential relapse markers for pancreatic cancer patients. First author DOI 10.1080/15384047.2018.1564565↗
- Pim-3 Regulates Stemness of Pancreatic Cancer Cells via Activating STAT3 Signaling Pathway. Co-author DOI 10.7150/jca.18628↗
- The usefulness of S100P, mesothelin, fascin, prostate stem cell antigen, and 14-3-3 sigma in diagnosing pancreatic adenocarcinoma in cytological specimens obta… Co-author DOI 10.1002/dc.21684↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Min Zhang · 1 shared paper, 2020 · strength 0.13
- Peng Yuan · 1 shared paper, 2020 · strength 0.13
- Yun Xi · 1 shared paper, 2020 · strength 0.13
- Biao Li · 1 shared paper, 2020 · strength 0.13
- Mo‐Fang Liu · 1 shared paper, 2020 · strength 0.13
- Feng Tang · 1 shared paper, 2021 · strength 0.13
- Gang Luo · 1 shared paper, 2021 · strength 0.13
- Weidong Ma · 1 shared paper, 2019 · strength 0.11
- Hui Li · 1 shared paper, 2019 · strength 0.11
- Xiuchao Wang · 1 shared paper, 2019 · strength 0.11
- Yingyi Li · 1 shared paper, 2017 · strength 0.10
- Zhen Wang · 1 shared paper, 2017 · strength 0.10
- Daniel C. Dim · 1 shared paper, 2014 · strength 0.05
- Hong Qi Peng · 1 shared paper, 2014 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.